Experimental Biology and Medicine 226:216-221 (2001)
© 2001 Society for Experimental Biology and Medicine
ORIGINAL ARTICLE
Bisphenol A Inhibits Testicular Functions and Increases Luteinizing Hormone Secretion in Adult Male Rats
Atsushi Tohei*,
Satoshi Suda*,
Kazuyoshi Taya
,
Takao Hashimoto
and
Hiroshi Kogo*,1
* Department of Pharmacology and
Department of Pathophysiology, Tokyo University of Pharmacy and Life Science, Hachioji, Tokyo 192-0392, Japan; and
Laboratory of Veterinary Physiology, Tokyo University of Agriculture and Technology, Fuchu, Tokyo183-0054,Japan
 |
Abstract
|
|---|
Effects of a xenobiotic estrogen, bisphenol A (BPA), on reproductive functions were investigated using adult male rats. BPA was dissolved into sesame oil and injected sc every day (1 mg/rat) for 14 days. Animals were killed by decapitation after the final administration of BPA, and the trunk blood, pituitary, and testes were collected. Plasma concentrations of prolactin were dramatically increased and pituitary contents of prolactin were slightly increased in the BPA group compared to the control group. Plasma concentrations of testosterone were decreased and plasma concentrations of LH were increased in BPA-treated rats compared to control rats. Testicular contents of inhibin were decreased in BPA-treated rats compared to control rats, although plasma concentrations of inhibin were not changed after administration of BPA. The testicular response to hCG for progesterone and testosterone release was decreased in BPA-treated rats. Administration of BPA did not change the pituitary response to luteinizing hormone-releasing hormone (LH-RH) in castrated male rats treated with testosterone. Male sexual behavior also was not changed as a result of BPA treatment. These results suggest that BPA directly inhibits testicular functions and the increased level of plasma LH is probably due to a reduction in the negative feedback regulation by testosterone. The testis is probably a more sensitive site for BPA action than the hypothalamuspituitary axis.
Key Words: bisphenol A reproductive functions male rats
 |
Introduction
|
|---|
It is becoming evident that many environmental chemicals bind to estrogen receptors, mimic or inhibit estrogenic actions, and may disturb endocrine systems in wildlife and humans (16). One such compound is bisphenol A (BPA), a monomer of polycarbonate plastics. BPA-based epoxy resins are widely used in consumer products, including composite dental sealants and the inner coating of food cans. BPA can be liberated from incompletely polymerized epoxy resins, and actually there have been several reports showing the presence of significant amounts of BPA in the liquid from canned vegetables (7) and in human saliva from patients treated with composite dental sealants (8). The estrogenic activities of BPA, which include binding to estrogen receptors, induction of progesterone receptors and promoting cell proliferation in estrogen-responsive MCF-7 breast cancer cells, have been demonstrated in in vitro systems. However, the potency of BPA was 34 orders of magnitude lower than that of estradiol (9). In addition to its estrogenic activities in MCF-7 cells, BPA stimulates prolactin (PRL) release in Fischer 344 rats (10), decreases plasma concentrations of testosterone in pubertal mice (11) and inhibits human chorionic gonadotropin (hCG)-stimulated steroidogenesis in mouse Leydig tumor cells (12). Other environmental xenobiotic estrogens, namely, alkylphenols, have also been reported to disrupt reproductive functions in rats (13,14).
It is clear that environmental xenobiotic estrogens such as bisphenol A and alkylphenols affect reproductive functions in experimental animals, and it has recently been hypothesized that exposure to estrogenic substances might account for the increasing frequency of infertility and the associated disorders of the male reproductive system in humans. However, there is little information on the effects of BPA on reproductive functions in adult males. In the present study, we determined the effects of BPA on adult male rat reproductive functions in vivo and investigated the sensitive site of BPA in the hypothalamus-pituitarygonadal axis.
 |
Materials and Methods
|
|---|
Animals and Treatments.
Adult male Wistar-Imamichi strain rats (300350 g) were obtained from the Institute for Animal Reproduction (Ibaraki, Japan). Rats were housed under controlled temperature and lighting conditions (12 hr light:12 hr dark, light on at 7:00 AM) and supplied with food and water ad libitum. BPA (bisphenol A, Aldrich Chemical Co. Inc., Milwaukee, WI) was dissolved in 0.2 ml sesame oil and injected sc at 0800 h every day for 2 weeks. Five to six animals were used in each experiment.
Effects of BPA on Pituitary and Testicular Functions.
To examine the effects of BPA on pituitary and testicular functions, five animals of each group were killed by decapitation at 0800 h 2 weeks after administration of BPA (1 mg/rat/day). The amount of BPA (1 mg) used in the present study was similar to the highest dose (8) of human exposure (931 µg in saliva from patients treated with composite dental sealants) reported in some previous studies (79). This dose and the duration of BPA administration were determined by the results from preliminary experiment. We confirmed that daily administration of BPA (1 mg) for 1 week had no effects on pituitary and testicular functions. Blood was collected in heparinized tubes and centrifuged for the determination of plasma concentrations of luteinizing hormone (LH), follicle-stimulating hormone (FSH), PRL, testosterone, and inhibin. After decapitation, the pituitary and testes were removed and weighed. Pituitary glands and testes were homogenized in 0.05 M phosphate-buffered saline (PBS) at 4°C. The supernatant and plasma were collected and stored frozen at -20°C until assay for LH, FSH, PRL, testosterone, and inhibin.
Effects of BPA on the Testicular Response to hCG.
To investigate the effects of BPA on testicular functions, hCG challenge was performed 2 weeks after administration of 100 µg or 1 mg BPA. Twenty-four hours before the experiment, a cannula was inserted into the right atrium via the external jugular vein in each rat for drawing blood samples. Ten IU hCG or vehicle was injected through the atrial cannula, and blood samples were taken for plasma progesterone and testosterone before the injection and 30, 60, 90, 120, 150, and 180 min after administration of hCG. Blood was centrifuged, and the supernatant was stored frozen at -20°C until assay for progesterone and testosterone.
Effects of BPA on the Pituitary Response to LH-RH for LH Release.
To examine the direct effects of BPA on pituitary function, especially LH secretion, LHRH challenge was performed 2 weeks after administration of BPA. Adult male rats were castrated 5 days before the initiation of BPA treatment, and the castrated rats received sc administration of BPA (1 mg) and testosterone propionate (75 µg) every day for 2 weeks. Twenty-four hours before the experiment, a cannula was implanted into the jugular vein in each rat for drawing blood samples. LHRH (250 ng) dissolved in 0.2 ml of 50% polyvinylpyrrolidone or vehicle was injected subcutaneously. Blood samples for plasma LH were taken from the cannula immediately before the injection and 0.25, 0.5, 1, 2, 3 and 4 hr after the injection. Blood was centrifuged, and the supernatant was stored frozen at -20°C until assay for LH.
Effects of BPA on Sexual Behavior.
To examine the effects of BPA on the central nervous system, tests of copulatory behavior were conducted between 2000 and 2200 h under dim illumination from a 25-W red bulb, by direct observation of males paired with proestrous female rats in semicircular aquaria with sawdust bedding on the floor as described previously (15, 16). Two weeks after administration of BPA (1 mg), each male was allowed an adaptation period of 5 min prior to introduction of the stimulus female. Upon its introduction, each male was scored for the number of mounts, intromissions, and ejaculations. Subsequently, the following six parameters were calculated for 30 min of behavioral tests: (i) the mount latency, time from introduction of the female to the first mount; (ii) intromission latency, time from induction of the female to the first intromission; (iii) ejaculation latency, time from the first intromission of each ejaculatory series to ejaculation; (iv) mount frequency, the number of mounts per each ejaculatory series; (v) intromission frequency, the number of intromissions per each ejaculatory series; and (vi) ejaculation frequency, the number of ejaculations during the test period.
Radioimmunoassay (RIA).
Concentrations of LH, FSH, and PRL were measured using National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) rat radioimmunoassay (RIA) kits for rat LH, FSH, and PRL. Hormones for iodination were rat LH-I-7, rat FSH-I-7, and rat PRL-I-5. The antisera used were anti-rat LH-S-10, anti-rat FSH-S-11, and anti-rat PRL-S-6. The results are expressed in terms of NIDDK rat LH-RP-2, FSH-RP-2, and PRL-RP-3. The intra- and inter-assay coefficients of variation were 5.5% and 8.9% for LH, 4.3% and 10.3% for FSH, and 5.8% and 7.6% for PRL, respectively.
Inhibin (17), progesterone, and testosterone (18) were measured by double-antibody RIAs using 125I-labeled radioligands as described previously. Antiserum to progesterone (GDN 337) was kindly provided by Dr. G.D. Niswender (Colorado State University, Fort Collins, CO), and antiserum to testosterone (FKA-102) was obtained from Cosmo Bio Co. (Tokyo, Japan). The intra- and inter-assay coefficients of variation were 3.7% and 6.4% for inhibin, 6.9% and 11.2% for progesterone, and 6.2% and 7.4% for testosterone, respectively.
Statistical Analyses.
All results were expressed as the mean ± SEM. The data for the hormone levels in plasma, pituitary, and testes were analyzed using one-way analysis of variance (ANOVA) followed by Fisher's protected least-significant difference (PLSD) test. Behavioral data were analyzed using MannWhitney U-tests. The effects of hCG challenges were analyzed using two-way ANOVA followed by Fisher's PLSD test; a value of P < 0.05 was considered significant.
 |
Results
|
|---|
Effects of BPA on Pituitary and Testicular Functions.
Plasma concentrations of LH and PRL were markedly increased by administration of BPA (1 mg) for 2 weeks (Fig. 1a,b
. Pituitary contents of LH and PRL were also increased in BPA-treated rats compared to control rats, although the effects of BPA were not statistically significant (Fig. 1c,d
). FSH levels in plasma and pituitary were not changed after administration of BPA (data not shown).Plasma concentrations of testosterone and testicular contents of inhibin were significantly decreased (Fig. 2a,d
), whereas testicular contents of testosterone and plasma concentrations of inhibin were not changed in BPA-treated rats compared to control rats (Fig. 2b,c
).

View larger version (49K):
[in this window]
[in a new window]
|
Figure 1. Plasma concentrations and pituitary contents of LH and PRL in adult male rats treated with BPA (1 mg) for 2 weeks. *P < 0.05 compared with control groups when analyzed using one-way ANOVA followed by Fisher's PLSD test.
|
|

View larger version (51K):
[in this window]
[in a new window]
|
Figure 2. Plasma concentrations and testicular contents of testosterone and inhibin in adult male rats treated with BPA (1 mg) for 2 weeks. *P < 0.05 compared with control groups when analyzed using one-way ANOVA followed by Fisher's PLSD test.
|
|
Effects of BPA on Testicular Response to hCG.
In response to hCG (10 IU), plasma concentrations of progesterone and testosterone were markedly increased in the control group. Testicular responses to hCG for progesterone and testosterone release were significantly suppressed (Fig. 3b,d
) as a result of treatment with high-dose BPA (1 mg), but administration of low-dose BPA (0.1 mg) did not affect either steroid (Fig. 3a,c
).

View larger version (38K):
[in this window]
[in a new window]
|
Figure 3. Effects of BPA on the testicular response to hCG for progesterone and testosterone release in adult male rats. Animals received sc daily administration of BPA (0.1 or 1 mg) for 2 weeks. Plasma concentrations of progesterone and testosterone were measured after a single iv injection of hCG (10 IU). *P < 0.05 compared with control when analyzed using two-way ANOVA followed by Fisher's PLSD test.
|
|
Effects of BPA on the Pituitary Response to Luteinizing Hormone-Releasing Hormone (LHRH) for LH Release.
Administration of BPA (1 mg) did not change plasma concentrations of LH at 0 time in castrated rats treated with testosterone (Fig. 4
), although plasma concentrations of LH were increased in testes-intact rats as a result of BPA administration (Fig.1a
). In castrated rats, pituitary LH response to LHRH also was not affected after administration of BPA.

View larger version (25K):
[in this window]
[in a new window]
|
Figure 4. Effects of BPA on the pituitary response to LH-RH for LH release in castrated adult male rats treated with testosterone (75 µg). Castrated male rats received sc daily administration of BPA (1 mg) and testosterone (75 µg) for 2 weeks. Plasma concentrations of LH were measured after a single sc injection of LHRH (250 ng) dissolved in 50% polyvinylpyrrolidone.
|
|
Effects of BPA on Sexual Behavior.
Tests of copulatory behavior were conducted using adult male rats treated with BPA (1 mg) for 2 weeks. Six parameters including the mount latency (control, 13.6 ± 3.75 min; BPA, 13.0 ± 6.27 min), intromission latency (control, 21.0 ± 6.37 min; BPA, 23.4 ± 12.29 min), ejaculation latency (control, 129.6 ± 29.85 min; BPA, 160.0 ± 43.47 min), mount frequency (control, 11.9 ± 3.34; BPA, 11.6 ± 3.19), intromission frequency (control, 4.7 ± 0.75; BPA, 3.8 ± 0.99), and ejaculation frequency (control, 3.6 ± 0.24; BPA, 3.4 ± 0.24) were calculated for 30 min of behavioral tests. Administration of BPA did not affect any of the parameters in male sexual behavior.
 |
Discussion
|
|---|
In the present study, administration of BPA significantly increased plasma concentrations of LH in adult male rats. Pituitary content of LH was also slightly increased in BPA-treated rats. In contrast, plasma concentrations of testosterone were decreased by BPA treatment. Testicular contents of inhibin were also significantly decreased in BPA-treated rats compared to control rats, although plasma concentrations of inhibin were not changed in adult male rats after administration of BPA. It has been well demonstrated that testosterone and inhibin are synthesized in Leydig and Sertoli cells, respectively, in adult male rats (19, 20). These findings suggest that BPA affects testicular functions in terms of Leydig and Sertoli cell functions and that the increased levels of plasma LH might be due to a reduction in the negative feedback regulation by testosterone. In contrast to LH levels, FSH levels in plasma and pituitary were not changed by BPA administration. Since FSH secretion is mainly regulated by inhibin (21), the lack of any change in FSH may be due to the unchanged plasma concentrations of inhibin in BPA-treated rats in the present study. Administration of BPA increased PRL secretion in adult male rats. This effect of BPA is probably the direct action to anterior pituitary. Estrogen is well known to stimulate PRL secretion by acting at the pituitary level (22, 23). A previous report has shown that BPA increased in vivo and in vitro PRL release in estrogen-sensitive Fischer 344 rats but not in Sprague Dawley rats (10). These results support our findings in the present study, and the Wistar-Imamichi strain rats used in the present study might be sensitive to xenobiotic estrogen in terms of PRL secretion. Hyperprolactinemia has been shown to cause reproductive dysfunction (15, 24), but this dysfunction is not mediated via direct action on the testis. More likely it acts at the level of the hypothalamuspituitary to inhibit LHRH and LH secretion (24, 25). Inhibition of LH secretion has been reported during hyperprolactinemia (26, 27). In the present study, LH secretion was not decreased, but rather it was elevated in response to BPA, suggesting an action of BPA directly on the testis to inhibit testosterone secretion.
In the hCG challenge test to examine testicular (Leydig) functions in detail, administration of BPA significantly inhibited the testicular response to hCG for progesterone and testosterone release. It has been shown that BPA decreased hCG-stimulated cAMP and progesterone production in cultured mouse Leydig tumor cells by inhibiting LH receptor-mediated signal transduction (12). This report indicated that the disturbance in signal transduction might be located between LH receptor and the adenylate cyclase, and that the effects of BPA were not related to estrogenic action as estradiol and diethylstilbestrol did not inhibit hCG-stimulated cAMP production (12). These results from the in vitro experiments agree with our in vivo results in the present study. The inhibition of hCG stimulated testosterone and progesterone release observed in BPA-treated rats may be due to the disturbance in the signal transduction between LH receptor and the adenylate cyclase. To examine the direct effects of BPA on LH secretion, LH-RH challenge was performed using castrated adult male rats treated with testosterone in the present study. Administration of BPA did not affect the plasma concentration of LH at time zero in castrated rats treated with testosterone, although plasma concentrations of LH were increased in testes-intact rats by BPA administration. In castrated rats, the pituitary response to LHRH for LH release also was not affected after administration of BPA. These results suggest that BPA has little direct action on gonadotroph and the increased levels of plasma LH observed in BPA-treated intact rats are due to a reduction in the negative feedback regulation by testosterone.
In the present study, administration of BPA did not affect any of the parameters in male sexual behavior. The regulation of masculine sexual behavior is a complex process, and testosterone is one of most important factors for promoting it (28). The inhibition of testosterone secretion in BPA-treated rats may have been not strong enough to interfere with male copulatory behavior in the present study and prolonged administration of BPA (1 mg) might be necessary to affect male sexual behavior.
The amount of BPA (1 mg) used in the present study was almost same as the highest dose (8) of human exposure (931 µg in saliva from patients treated with composite dental sealants) reported in some previous studies (79), but this amount was a high dose for adult male rats weighing 300350 g. Animals received sc injection of BPA in the present study because 80% of the administrated BPA was eliminated in fecal and 11% in urine within 3 days after its oral administration (29, 30). However, humans and animals are usually exposed to BPA orally. Experiments for the comparison with different routes of administration will be needed to fully ascertain the effects of BPA on male reproductive functions.
In conclusion, BPA directly inhibits testicular functions and increases plasma levels of LH. This increased level of LH is due to a reduction in the negative feedback regulation by testosterone, and the testis may be a more sensitive site for BPA than the hypothalamuspituitary axis.
 |
Acknowledgments
|
|---|
We are grateful to Mr. H Koibuchi and Dr. G Watanabe, Tokyo University of Agriculture and Technology, for their technical assistance; the Rat Pituitary Hormone Distribution Program, NIDDK, Bethesda, MD, for providing RIA materials; Dr. G.D. Niswender, Animal Reproduction and Biotechnology Laboratory, Colorado State University, Fort Collins, CO, for providing antiserum to progesterone (GDN 337); Drs. P.F. Terranova and B.K. Petroff, Department of Molecular and Integrative Physiology, The University of Kansas, Kansas City, KS, for valuable suggestions; and Professor S. Saida, Tokyo University of Pharmacy and Life Science, for proofreading of the manuscript.
 |
Footnotes
|
|---|
This work was supported in part by a USJapan Cooperative Research Grant from the Japan Society for the Promotion of Science.
1 To whom correspondence should be addressed at Department of Pharmacology, Tokyo University of Pharmacy and Life Science, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan. E-mail: kogo{at}ps.toyaku.ac.jp 
 |
References
|
|---|
-
Guillette LJ Jr, Gross TS, Masson GR, Matter JM, Percival HF, Woodward AR. Developmental abnormalities of the gonad and abnormal sex hormone concentrations in juvenile alligators from contaminated and control lakes in Florida. Environ Health Perspect 102:680688, 1994.[Medline]
-
Guillette LJ Jr, Pickford DB, Crain DA, Rooney AA, Percival HF. Reduction in penis size and plasma testosterone concentrations in juvenile alligators living in contaminated environment. Gen Comp Endocrinol 101:3234, 1996.[Medline]
-
Jobling S, Sheahan D, Osborne JA, Mathiessen P, Sumpter JP. Inhibition of testicular growth in rainbow trout exposed to estrogenic alkylphenolic chemicals. Environ Toxicol Chem 15:194202, 1996.
-
Korach KS. Editorial: Surprising places of estrogenic activity. Endocrinology 132:22772278, 1993.[Medline]
-
Stone R. Environmental estrogens stir debate. Science 265:308310, 1994.[Free Full Text]
-
White R, Jobling S, Hoare SA, Sumpter JP, Parker MG. Environmental persistent alkylphenolic compounds are estrogenic. Endocrinology 135:175182, 1994.[Abstract]
-
Brotons JA, Olea-Serrano MF, Villalobos M, Pedraza V, Olea N. Xenoestrogens released from lacquer coatings in food cans. Environ Health Perspect 103:608612, 1995.[Medline]
-
Olea N, Pulgar R, Perez P, Olea-Serrano F, Rivas A, Novillo-Fertrell A, Pedraza V, Soto AM, Sonnenschein C. Estrogenicity of resin-based composites and sealants used in dentistry. Environ Health Perspect 104:298305, 1996.[Medline]
-
Krishnan AV, Stathis P, Permuth SF, Tokes L, Feldman D. Bisphenol-A: An estrogenic substances is released from polycarbonate flasks during autoclaving. Endocrinology 132:22792286, 1993.[Abstract]
-
Steinmetz R, Brown NG, Allen DL, Bigsby RM, Ben-Jonathan N. The environmental estrogen bisphenol A stimulates prolactin release in vitro and vivo. Endocrinology 138:17801786, 1997.[Abstract/Free Full Text]
-
Takao T, Nanamiya W, Nagano I, Asaba K, Kawabata K, Hashimoto K. Exposure with the environmental estrogen bisphenol A disrupts the male reproductive tract in young mice. Life Sci 65:23512357, 1999.[Medline]
-
Nikula H, Talonpoika T, Kaleva M, Toppari J. Inhibition of hCG-stimulated steroidogenesis in cultured mouse Leydig tumor cells by bisphenol A and octylphenols. Toxicol Appl Pharmacol 157:166173, 1999.[Medline]
-
Blake CA, Boockfor FR. Chronic administration of the environmental pollutant 4-tert-octylphenol to adult male rats interferes with the secretion of luteinizing hormone, follicle-stimulating hormone, prolactin and testosterone. Biol Reprod 57:255266, 1997.[Abstract]
-
Boockfor FR, Blake CA. Chorionic administration of 4-tert-octylphenol to adult male rats causes shrinkage of the testes and male accessory sex organs, disrupts spermatogenesis, and increases the incidence of sperm deformities. Biol Reprod 57:267277, 1997.[Abstract]
-
Tohei A, Saito TR, Hokao R, Furudate S-I, Takahashi KW. Effects of bromocriptine (CB-154) treatment on copulatory behavior in hyperprolactinemic adult male rats. Exp Anim 43:427431, 1994.
-
Tohei A, Watanabe G, Taya K. Effects of thyroidectomy or thiouracil treatment on copulatory behavior in adult male rats. J Vet Med Sci 60:281285, 1998.[Medline]
-
Hamada T, Watanabe G, Kokuho T, Taya K, Sasamoto S, Hasegawa Y, Miyamoto K, Igarashi M. Radioimmunoassay of inhibin in various mammals. J Endocrinol 122:697704, 1989.[Abstract]
-
Taya K, Watanabe G, Sasamoto S. Radioimmunoassay for progesterone, testosterone and estradiol-17ß using 125I-iodohistamine radioligands. Jpn J Anim Reprod 31:186197, 1985.
-
Bardin CW, Cheng CY, Mustow NA, Gunsalus GL. The Sertoli cell. In: Knobil E, Neill JD, Eds. The physiology of reproduction. New York, Raven Press, pp933974, 1988.
-
Hall PF. Testicular steroid synthesis: Organization and regulation. In: Knobil E, Neill JD, Eds. The physiology of reproduction. New York, Raven Press, pp975998, 1988.
-
De Jong FH. Inhibin. Physiol Rev 68:555607, 1988.[Abstract/Free Full Text]
-
Ben-Jonathan N, Arbogast LA, Hyde JF. Neuroendocrine regulation of prolactin release. Prog Neurobiol 33:399447, 1989.[Medline]
-
Lamberts SW, Macleod RM. Regulation of prolactin secretion at the level of the lactotroph. Physiol Rev 70:279318, 1990.[Free Full Text]
-
Adler RA. The anterior pituitary-grafted rat: A valid model of chronic hyperprolactinemia. Endocr Rev 7:302313, 1986.[Medline]
-
Bartke A, Smith MS, Michael SD, Peron FG, Dalterio S. Effects of experimentally induced chronic hyperprolactinemia on testosterone and gonadotropin levels in male rats and mice. Endocrinology 100:182186, 1977.[Abstract]
-
Koike K, Aono T, Miyake A, Tasaka K, Chatani F, Kurachi K. Effect of pituitary transplants on the LHRH concentrations in the medial basal hypothalamus and hypophysial portal blood. Brain Res 301:253258, 1984.[Medline]
-
Park S-K, Keenan MW, Selmanoff M. Graded hyperprolactinemia first suppresses LH pulse frequency and then pulse amplitude in castrated male rats. Neuroendocrinology 58:448453, 1993.[Medline]
-
Sachs BD, Meisel RL. Physiology of male sexual behavior. In: Knobil E, Neill JD, Eds. The physiology of reproduction. New York, Raven Press, pp13931486, 1988.
-
Climie IJG, Hutson DH, Stoydin G. Metabolism of epoxy resin component 2,2-bis[4-(2,3-epoxypropoxy)phenyl]propane, the diglycidyl ether of bisphenol A (DGEBPA) in the mouse. Part I. A comparison of the fate of a single dermal application and of a single oral dose of 14C DGEBPA. Xenobiotica 11:391399, 1981.[Medline]
-
Climie IJG, Hutson DH, Stoydin G. Metabolism of epoxy resin component 2,2-bis[4-(2,3-epoxypropoxy)phenyl]propane, the diglycidyl ether of bisphenol A (DGEBPA) in the mouse. Part II. Identification of metabolites in urine and faeces following a single oral dose of 14C DGEBPA. Xenobiotica 11:401424, 1981.[Medline]
Received for publication May 22, 2000.
Accepted for publication November 1, 2000.
This article has been cited by other articles:

|
 |

|
 |
 
W. V. Welshons, S. C. Nagel, and F. S. vom Saal
Large Effects from Small Exposures. III. Endocrine Mechanisms Mediating Effects of Bisphenol A at Levels of Human Exposure
Endocrinology,
June 1, 2006;
147(6):
s56 - s69.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. W. Tyl, C. B. Myers, M. C. Marr, B. F. Thomas, A. R. Keimowitz, D. R. Brine, M. M. Veselica, P. A. Fail, T. Y. Chang, J. C. Seely, et al.
Three-Generation Reproductive Toxicity Study of Dietary Bisphenol A in CD Sprague-Dawley Rats
Toxicol. Sci.,
July 1, 2002;
68(1):
121 - 146.
[Abstract]
[Full Text]
[PDF]
|
 |
|